Terazosin
Product Images NDC 53217-212

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 53217-212). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Terazosin Hydrochloride Chemical Structure (Terazosin Usp 2mg 1)

Chemical structure of Terazosin hydrochloride, showing its detailed molecular arrangement including aromatic rings, nitrogen atoms, and functional groups.*

FDA Label Image

Figure 1 (Terazosin Usp 2mg 2)

Two line graphs comparing Terazosin and placebo groups. The left graph shows mean change in total symptom score from baseline over 0 to 3 months, with Terazosin decreasing symptoms more than placebo. The right graph shows mean increase in peak flow rate from baseline over the same period, where Terazosin shows a greater increase compared to placebo. Sample sizes are indicated as N=54-55 per group.*

FDA Label Image

Figure 2 (Terazosin Usp 2mg 3)

A line graph showing the mean change from baseline over 30 months. The x-axis represents time in months, from 0 to 30, and the y-axis shows the mean change from baseline with values ranging from 0 to -7. Data points marked with an asterisk indicate statistically significant changes at multiple time intervals throughout the 30 months.*

FDA Label Image

Figure 3 (Terazosin Usp 2mg 4)

A line graph showing mean change from baseline in mL/sec over a 30-month period, with months marked on the x-axis and mean change values on the y-axis. The graph includes data points with error bars and asterisks indicating statistical significance at multiple time points after baseline.*

FDA Label Image

Image Label (Terazosin Usp 2mg 5)

Label for Terazosin USP 2mg capsules, 30 count, packaged by Aidarex Pharmaceuticals LLC. The label includes dosage strength, capsule count, generic indication for Hytrin, active ingredient as Terazosin Hydrochloride equivalent to 2mg Terazosin, and identification of an ivory oblong capsule with imprint TL 384. Manufacturer listed as Jubilant Cadista Pharmaceuticals Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.